Literature DB >> 11250495

Monotherapy with anti-CD40 ligand antibody (IDEC 131) for non-human primate allograft heart transplantation.

S Pfeiffer1, G L Zorn, A M Azimzadeh, J Atkinson, R Newman, R N Pierson.   

Abstract

Entities:  

Year:  2001        PMID： 11250495     DOI： 10.1016/s1053-2498(00)00568-4

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  6 in total

Review 1.  Advances in the immunology of heart transplantation.

Authors:  Joren C Madsen
Journal:  J Heart Lung Transplant       Date:  2017-10-20       Impact factor: 10.247

Review 2.  Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation.

Authors:  Zachary Fitch; Robin Schmitz; Jean Kwun; Bernhard Hering; Joren Madsen; Stuart J Knechtle
Journal:  Transplant Rev (Orlando)       Date:  2019-04-05       Impact factor: 3.943

Review 3.  Induction of transplantation tolerance in non-human primate preclinical models.

Authors:  Douglas A Hale; Kiran Dhanireddy; David Bruno; Allan D Kirk
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

Review 4.  Primate models in organ transplantation.

Authors:  Douglas J Anderson; Allan D Kirk
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

5.  Comparative Evaluation of αCD40 (2C10R4) and αCD154 (5C8H1 and IDEC-131) in a Nonhuman Primate Cardiac Allotransplant Model.

Authors:  Natalie A OʼNeill; Tianshu Zhang; Gheorghe Braileanu; Wenji Sun; Xiangfei Cheng; Alena Hershfeld; Christopher T Laird; Anthony Kronfli; Lindsay A Hock; Siamak Dahi; Natalia Kubicki; Evelyn Sievert; Wessam Hassanein; Arielle Cimeno; Richard N Pierson; Agnes M Azimzadeh
Journal:  Transplantation       Date:  2017-09       Impact factor: 4.939

Review 6.  Update on CD40 and CD154 blockade in transplant models.

Authors:  Tianshu Zhang; Richard N Pierson; Agnes M Azimzadeh
Journal:  Immunotherapy       Date:  2015-08-13       Impact factor: 4.196
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.